Focal liver lesions: Whether a standard dose (0.05mmol/kg) gadobenate dimeglumine can provide the same diagnostic data as the 0.1mmol/kg dose
Authors:
- Erkan GokceEGErkan Gokce
- Murat DanaciMDMurat Danaci
- Ilkay Koray BayrakIBIlkay Koray Bayrak
- H. Baris DirenHDH. Baris Diren
- 1 April 2008
- journal article
- research article
- Published by Elsevier in European Journal of Radiology
- Vol. 66 (1) , 65-74
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Improved Detection of Focal Liver Lesions at MR Imaging: Multicenter Comparison of Gadoxetic Acid–enhanced MR Images with Intraoperative FindingsRadiology, 2004
- Low-Dose Gadobenate Dimeglumine Versus Standard Dose Gadopentetate Dimeglumine for Contrast-Enhanced Magnetic Resonance Imaging of the LiverInvestigative Radiology, 2003
- Low-Dose Gadobenate Dimeglumine-Enhanced MRI in the Detection and Characterization of Focal Liver LesionsAcademic Radiology, 2002
- Focal Nodular Hyperplasia: Morphologic and Functional Information from MR Imaging with Gadobenate DimeglumineRadiology, 2001
- Contrast Agents for MR Imaging of the LiverRadiology, 2001
- Gadobenate Dimeglumine 0.5 M Solution for Injection (MultiHance®): Pharmaceutical Formulation and Physicochemical Properties of a New Magnetic Resonance Imaging Contrast MediumJournal of Computer Assisted Tomography, 1999
- Safety, tolerance, biodistribution, and MR imaging enhancement of the liver with gadobenate dimeglumine: Results of clinical pharmacologic and pilot imaging studies in nonpatient and patient volunteersAcademic Radiology, 1999
- Hepatic lesions: detection with ferumoxide-enhanced T1-weighted MR imaging.Radiology, 1997
- Comparison of gadolinium chelates with manganese-DPDP for liver lesion detection and characterization: Preliminary resultsMagnetic Resonance Imaging, 1996
- Contrast-enhanced MR imaging of the liver.Radiology, 1992